2001
DOI: 10.1159/000049735
|View full text |Cite
|
Sign up to set email alerts
|

Negative Effect of Transforming Growth Factor-Beta-1 on Intestinal Anastomotic Tissue Regeneration

Abstract: To examine the involvement of transforming growth factor-β1 (TGF-β1) in intestinal anastomotic repair, we administered a TGF-β1-neutralizing antibody to rats after operation, and then examined its influence on the healing process and interaction with other peptide growth factors. Thirty male Sprague-Dawley rats were subjected to primary anastomosis after transection of the small intestine (n = 30) and treated by intraperitoneal administration of IgG (n = 15) or the TGF-β1<… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0
1

Year Published

2004
2004
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 21 publications
0
8
0
1
Order By: Relevance
“…Surprisingly, the degree to which TGF-␤ 1 can account for the varied pathologies in these disorders and the mechanism and reversibility of TGF-␤ 1 -induced fibrosis are poorly understood. In addition, our knowledge of TGF-␤ effector pathways is limited and does not explain how TGF-␤ 1 stimulates fibrosis while simultaneously inducing structural cell apoptosis and tissue injury, and inhibiting epithelialization and wound healing (23)(24)(25)(26)(27). Lastly, because TGF-␤ 1 -induced fibrosis and apoptosis are considered distinct tissue responses, the role of apoptosis in TGF-␤ 1 -induced fibrosis has not been defined.…”
Section: Introductionmentioning
confidence: 99%
“…Surprisingly, the degree to which TGF-␤ 1 can account for the varied pathologies in these disorders and the mechanism and reversibility of TGF-␤ 1 -induced fibrosis are poorly understood. In addition, our knowledge of TGF-␤ effector pathways is limited and does not explain how TGF-␤ 1 stimulates fibrosis while simultaneously inducing structural cell apoptosis and tissue injury, and inhibiting epithelialization and wound healing (23)(24)(25)(26)(27). Lastly, because TGF-␤ 1 -induced fibrosis and apoptosis are considered distinct tissue responses, the role of apoptosis in TGF-␤ 1 -induced fibrosis has not been defined.…”
Section: Introductionmentioning
confidence: 99%
“…A number of studies demonstrate that, in the proper setting, TGF-b 1 is essential for wound healing, stimulates matrix molecule deposition and angiogenesis, and is an essential mediator of the pathologic scarring in fibrotic disorders (2)(3)(4)(5)(6). On the other hand, TGF-b 1 can also induce tissue injury and cellular apoptosis, decrease epithelialization, and inhibit wound healing (7)(8)(9)(10)(11)(12). The ''contradictory'' and complex nature of these responses reflects an inadequate understanding of the mechanisms that TGF-b 1 uses to induce tissue responses.…”
mentioning
confidence: 99%
“…Specifically, TGF stimulates proliferation of confluent vascular smooth muscle cells and ASMCs, but inhibits the proliferation of the same cells when they are subconfluent [40–43]. Also in a low dose TGF- β 1 stimulates proliferation of fibroblasts, chondrocytes, and arterial smooth muscle cells, but a high dose of TGF- β 1 inhibits the proliferation of the same cells [3944]. The induction of proliferation of bovine tracheal ASMCs in the presence of TGF is accompanied by activation of the MAPK pathway [37, 45].…”
Section: Discussionmentioning
confidence: 99%